A career in quantitative trading or research is one of the most exciting and intellectually rewarding paths in finance.

Cellectar Biosciences Inc (CLRB) progresses with regulatory approvals and partnerships, while navigating financial hurdles for future growth.

On Thursday evening, OpenAI CEO Sam Altman posted on X that ChatGPT has started following custom instructions to avoid using em-dashes. “Small-but-happy win: If you tell ChatGPT not to use em-dashes ...

Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...

The latest round of country climate plans ‘barely move the needle’ on future warming, the head of the UN Environment ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

Large financial institutions that engage in regulatory arbitrage by exploiting regulatory frameworks across jurisdictions to minimise regulatory burdens may reduce costs but may also increase risks ...

Discover why EMX Royalty Corporation’s merger may boost shareholder value with higher revenue, premium returns, and gold ...

In the short run, when firms cannot reassign labor, change suppliers, or adjust technologies, output losses ripple through every downstream stage of production. A shortage of a single key input can ...

Need a quote from a Motley Fool analyst? After today's presentation, participants of this call are advised that the audio of ...

Discover a practical blueprint for building a modern, intelligence-driven threat program aligned with enterprise risk and ...

The Texas Longhorns have a challenging end to the season, and a college football analyst makes a case for them making the ...